3 Catalysts That Could Send Teva Stock to $40 and Beyond

Twelve of the 15 analysts surveyed by S&P Global ( SPGI +1.32%) in April rated the pharmaceutical stock as a "buy" or "strong ...
Pharmabiz

Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection

Belief Pharmaceuticals Group announced that BM-H901 injection, (generic name: Popedacoq injection) has been officially approved by the Macau Drug Administration for the treatment of adult patients ...
Utusan Malaysia

Sciwind Biosciences Announces Ecnoglutide Injection Approved by China’s National Medical Products Administration (NMPA) for Chronic Weight Management

HANGZHOU, China, March 6, 2026 /PRNewswire/ — Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for ...
Neurology Advisor

FDA Accepts NDA for Once-Monthly Olanzapine Injection for Schizophrenia

Clinical trial data support the NDA for TEV-'749, demonstrating that once-monthly olanzapine improves symptoms in patients with schizophrenia. The Food and Drug Administration (FDA) has accepted for ...
Investing

FDA accepts Teva’s application for monthly olanzapine injection

PARSIPPANY, N.J. and TEL AVIV - Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Medincell (Euronext:MEDCL) announced today that the U.S. Food and Drug Administration has accepted their ...
The Globe and Mail

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly ...

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation 1 If approved, TEV-'749 could help ...
live.euronext

Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) ...